M. Castro

Myoclonus–dystonia syndrome: ε‐sarcoglycan mutations and phenotype

G. Deuschl, M. Vidailhet, A. Kupsch, 2002, Annals of neurology.

Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies.

M. Dichgans, C. Opherk, J. Herzog, 2005, Archives of neurology.

Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome

T. Meitinger, T. Strom, D. Berg, 2001, Nature Genetics.

Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome.

T. Meitinger, T. Strom, D. Berg, 2001, Nature genetics.

Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson′s disease

Thomas Gasser, Erwin Ott, F. Asmus, 2003, Neurogenetics.